The compound is contraindicated in subjects with hypersensitivity to the active ingredient or any of the product's components. People with a personal or family history of medullary thyroid cancer (MTC) or affected by multiple endocrine neoplasia type 2 should not take<unk> , because it could increase the risk of these cancers.
Dulaglutide
Semaglutide
Albiglutide
Teduglutide
Liraglutide
Exenatide
Linagliptin
Saxagliptin